KoBioLabs, Inc (KOSDAQ:348150)
2,810.00
+130.00 (4.85%)
At close: Oct 16, 2026
| Market Cap | 54.57B -48.8% |
| Revenue (ttm) | 75.41B +8.5% |
| Net Income | -4.80B |
| EPS | -247.39 |
| Shares Out | 19.42M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,612 |
| Open | 2,750.00 |
| Previous Close | 2,680.00 |
| Day's Range | 2,695.00 - 2,890.00 |
| 52-Week Range | 2,310.00 - 8,730.00 |
| Beta | 0.11 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |